Exelixis reported $316K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Akebia Therapeutics AKBA:US $ 0M 0M
Amgen AMGN:US $ 31989M 112M
AstraZeneca AZN:LN 387M 59M
Bayer BAYN:GR € 2515M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Cytokinetics CYTK:US $ 0.08M 0.01M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Esperion Therapeutics ESPR:US $ 27K 1000
Exelixis EXEL:US $ 0.32M 0M
Genmab GEN:DC DK 66M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Macrogenics MGNX:US $ 0.61M 0.01M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Puma Biotechnology PBYI:US $ 0M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Takeda 4502:JP Y 1676263M 7138M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Xencor XNCR:US $ 0.58M 0M
YTE INCY:US $ 0.22M 0M